Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer's Disease Therapy.

MLA

Ugbaja, Samuel C., et al. “Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy.” Molecules, vol. 27, no. 14, July 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/molecules27144372.

APA

Ugbaja, S. C., Lawal, I. A., Abubakar, B. H., Mushebenge, A. G., Lawal, M. M., & Kumalo, H. M. (2022). Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy. Molecules, 27(14), N.PAG. https://doi.org/10.3390/molecules27144372

Chicago

Ugbaja, Samuel C., Isiaka A. Lawal, Bahijjahtu H. Abubakar, Aganze G. Mushebenge, Monsurat M. Lawal, and Hezekiel M. Kumalo. 2022. “Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy.” Molecules 27 (14): N.PAG. doi:10.3390/molecules27144372.